Cargando…
Maternal proteomic profiling reveals alterations in lipid metabolism in late-onset fetal growth restriction
Fetal growth restriction defined as the failure to achieve the fetal genetic growth potential is a major cause of perinatal morbidity and mortality. The role of maternal adaptations to placental insufficiency in this disorder is still not fully understood. We aimed to investigate the biological proc...
Autores principales: | Paules, Cristina, Youssef, Lina, Miranda, Jezid, Crovetto, Francesca, Estanyol, Josep Maria, Fernandez, Guerau, Crispi, Fatima, Gratacós, Eduard |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7713381/ https://www.ncbi.nlm.nih.gov/pubmed/33273667 http://dx.doi.org/10.1038/s41598-020-78207-3 |
Ejemplares similares
-
Paired maternal and fetal metabolomics reveal a differential fingerprint in preeclampsia versus fetal growth restriction
por: Youssef, Lina, et al.
Publicado: (2021) -
Hemopexin and α(1)-microglobulin heme scavengers with differential involvement in preeclampsia and fetal growth restriction
por: Youssef, Lina, et al.
Publicado: (2020) -
Complement and coagulation cascades activation is the main pathophysiological pathway in early-onset severe preeclampsia revealed by maternal proteomics
por: Youssef, Lina, et al.
Publicado: (2021) -
The Interplay between Pathophysiological Pathways in Early-Onset Severe Preeclampsia Unveiled by Metabolomics
por: Youssef, Lina, et al.
Publicado: (2022) -
Mediterranean diet, Mindfulness-Based Stress Reduction and usual care during pregnancy for reducing fetal growth restriction and adverse perinatal outcomes: IMPACT BCN (Improving Mothers for a better PrenAtal Care Trial BarCeloNa): a study protocol for a randomized controlled trial
por: Crovetto, Francesca, et al.
Publicado: (2021)